
Globus And NuVasive Take Spinal Fusion To A New Level (NYSE:GMED)
Mohammed Haneefa Nizamudeen For med-tech companies with meaningful products/technology and a market capitalization below $10 billion, it often seems like their acquisition is a “when, not if” type of question, and that’s particularly true in […]